Point72 Asset Management
BIOA

Point72 Asset Management’s BioAge Labs BIOA Stock Holding History

Point72 Asset Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-41,180
Closed -$545K – 4643
2025
Q4 		$545K Buy
+41,180
New +$365K ﹤0.01% 3191
2024
Q4 		– Sell
-2,700
Closed -$56.2K – 2536
2024
Q3 		$56.2K Buy
+2,700
New +$54.1K ﹤0.01% 1896

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Point72 Asset Management's BIOA Position: Q1 2026 in Review

Point72 Asset Management sold out of BioAge Labs (BIOA) in Q1 2026, closing a stake of 41,180 shares — an estimated $545K sold.

Point72 Asset Management first reported a position in BIOA in Q3 2024 and held it in 2 quarters. The position peaked at $545K in Q4 2025. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Point72 Asset Management reported no remaining BioAge Labs position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 41,180 BioAge Labs shares in Q1 2026, an estimated $545K.
  • Point72 Asset Management first reported a position in BioAge Labs in Q3 2024 and held it in 2 quarters.
  • Point72 Asset Management's BioAge Labs position peaked at $545K in Q4 2025.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.